Published June 8, 2021
| Version v4
Dataset
Open
Blood Cell Transcriptomics and Proteomics of Axial Spondyloarthritis patients undergoing adalimumab treatment
Description
This study aims at identifying molecular biomarkers differentiating good responders and non-responders to treatment with TNF inhibitors (TNFi), among patients with axial spondyloarthritis (axSpA). Publication: Biomolecules 2024, 14(3), 382; https://doi.org/10.3390/biom14030382
Files
Files
(38.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:7a93e493884226aec1fe22f7ed51af47
|
2.1 MB | Download |
|
md5:4a724e7fcfbf731bc4b2d6e0dd44b0fe
|
1.8 MB | Download |
|
md5:b91946b93a8039d573a2868bfebf26fa
|
30.9 MB | Download |
|
md5:9918f381c5b26590cbee8c4de0c07f0b
|
1.1 MB | Download |
|
md5:3222c67e1ecdd657f4daa3c38c863ae5
|
22.1 kB | Download |
|
md5:b345b56e12fb9a80f20fc423e7db3391
|
2.0 MB | Download |
|
md5:75ad018f67c54281d8ad40629679c85b
|
21.9 kB | Download |
|
md5:26e5363c77135e975b1eca2ba608e4b0
|
22.1 kB | Download |
|
md5:e2ffc2ef8d302c4a3d913a9df6f9cda1
|
22.6 kB | Download |
|
md5:147e68e3ca5e83d51e99824256b39808
|
21.9 kB | Download |
|
md5:ebef1786747b69969ceb5e912fb5036e
|
22.7 kB | Download |
|
md5:c230146535bd16d029bea0e66893c8c4
|
19.7 kB | Download |
Additional details
Related works
- Is published in
- Journal article: 10.3390/biom14030382 (DOI)